WuXi PharmaTech Appoints Deepak Hegde as VP of Formulation Development Services

WuXi PharmaTech Appoints Deepak Hegde as VP of Formulation Development Services

July 24, 2007

    SHANGHAI, China, July 24 /Xinhua-PRNewswire/ -- WuXi
PharmaTech, China's leading supplier of pharmaceutical
R&D outsourcing services announced today the
appointment of Dr. Deepak Hegde as Vice President of
Formulation Development Services.

    (Logo: http://www.xprn.com.cn/xprn/sa/200611271812.jpg
)

    Before joining WuXi PharmaTech, Dr. Hegde served as
General Manager of Drug Delivery Research Lab at USV Ltd,
one of the largest Indian generic pharmaceutical companies.
 In this position, Dr. Hedge oversaw the development and
registration of formulations to be exported to the American
and European markets.  His undertakings at USV Ltd involved
closely collaborating with the US-FDA on Abbreviated New
Drug Applicant (ANDA) products and EMEA for the Product
Dossiers for the European markets.

    Prior to joining USV Ltd, Dr. Hegde worked in Sandoz
(the generic arm of Novartis).  At Sandoz, he implemented
cutting-edge drug development technology transfers from
Novartis development sites in India to Novartis commercial
launch sites in Austria, Bangladesh, and South Africa.

    Dr. Hegde's formulation and commercial manufacturing
acumen, coupled with his operation experience makes him a
valuable strategic addition to WuXi PharmaTech's rapidly
growing Pharmaceutical Development Services (PDS) division.
 In his new role as Vice President of Formulation
Development Services, Dr. Hegde will oversee the company's
growing portfolio of formulation based service offerings. 
Dr. Hegde will report directly to Dr. Ge Li, Chairman and
Chief Executive Officer of WuXi PharmaTech.

    "I am excited to welcome Dr. Hegde to WuXi
PharmaTech.  His strong and diverse industrial and
operational background will be a great asset to our growing
PDS division," commented Dr. Ge Li, Chairman and CEO of
WuXi PharmaTech.

    Dr. Hegde received his Bachelor of Pharmacy degree from
the University of Mumbai (formerly the University of Bombay)
before going on to receive a Master of Pharmacy in
Pharmacognosy and Phytochemistry from Banaras Hindu
University.  He returned to University of Mumbai to earn a
Ph.D. in Biopharmaceutics and Pharmacokinetics in 1996, and
has most recently received a Master of Financial Management
from Somaiya Institute of Management Studies and Research. 
Dr. Hegde is a lifetime member of the Indian Pharmaceutical
Association.
 
    About WuXi PharmaTech Co., Ltd.

    Founded in 2000, Shanghai-based WuXi PharmaTech is
China's leading drug R&D service company. As a
research-driven and customer-focused company, WuXi
PharmaTech offers global pharmaceutical and
biopharmaceutical companies a diverse, value-added, and
fully integrated portfolio of outsourcing services ranging
from discovery chemistry, and process chemistry to service
biology, bioanalytical chemistry, and large scale GMP
manufacturing. WuXi PharmaTech assists its global partners
in shortening the cycle and lowering the cost of drug
discovery and development by providing cost-effective and
efficient outsourcing solutions that save our clients both
time and money. Currently, our customer list consists of 9
of the top 10 pharmaceutical companies in the world. For
more information, please visit: 
http://www.wuxipharmatech.com .


    For more information, please contact:

     Sherry Shao
     Tel:   [phone]
     Email: [e-mail]